HDL and Cholesterol Ester Transfer Protein (CETP)
- 17 May 2022
- book chapter
- Published by Springer Nature
- Vol. 1377, 13-26
Abstract
Cholesterol ester transfer protein (CETP) is important clinically and is one of the major targets in cardiovascular disease studies. With high conformational flexibility, its tunnel structure allows unforced movement of high-density lipoproteins (HDLs), VLDLs, and LDLs. Research in reverse cholesterol transports (RCT) reveals that the regulation of CETP activity can change the concentration of cholesteryl esters (CE) in HDLs, VLDLs, and LDLs. These molecular insights demonstrate the mechanisms of CETP activities and manifest the correlation between CETP and HDL. However, animal and cell experiments focused on CETP give controversial results. Inhibiting CETP is found to be beneficial to anti-atherosclerosis in terms of increasing plasma HDL-C, while it is also claimed that CETP weakens atherosclerosis formation by promoting RCT. Currently, the CETP-related drugs are still immature. Research on CETP inhibitors is targeted at improving efficacy and minimizing adverse reactions. As for CETP agonists, research has proved that they also can be used to resist atherosclerosis. Keywords Cholesterol ester transfer protein Anti-atherosclerosis Reverse cholesterol transport CETP inhibitor CETP agonistsKeywords
This publication has 85 references indexed in Scilit:
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- Structural basis of transfer between lipoproteins by cholesteryl ester transfer proteinNature Chemical Biology, 2012
- Probucol alleviates atherosclerosis and improves high density lipoprotein functionLipids in Health and Disease, 2011
- Pharmacologic Suppression of Hepatic ATP-Binding Cassette Transporter 1 Activity in Mice Reduces High-Density Lipoprotein Cholesterol Levels but Promotes Reverse Cholesterol TransportCirculation, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Dysfunctional HDL as a Diagnostic and Therapeutic TargetArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007
- High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced ApoptosisBiochemical and Biophysical Research Communications, 2000
- SimvastatinDrugs, 1990